5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.96▲ | 1.96▲ | 1.96▲ | 1.91▲ | 1.85▲ |
MA10 | 1.96▲ | 1.95▲ | 1.94▲ | 1.94▲ | 1.58▲ |
MA20 | 1.96▲ | 1.94▲ | 1.94▲ | 1.92▲ | 1.31▲ |
MA50 | 1.95▲ | 1.92▲ | 1.86▲ | 1.58▲ | 1.13▲ |
MA100 | 1.93▲ | 1.86▲ | 1.95▲ | 1.30▲ | 1.00▲ |
MA200 | 1.94▲ | 1.94▲ | 1.78▲ | 1.15▲ | 3.87▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.002▲ | 0.002▲ | -0.024▼ | 0.072▲ |
RSI | 57.851▲ | 59.106▲ | 59.479▲ | 58.345▲ | 65.355▲ |
STOCH | 34.444 | 82.576▲ | 78.743 | 39.086 | 76.652 |
WILL %R | -14.286▲ | -8.333▲ | -8.333▲ | -47.788 | -21.736▲ |
CCI | 40.657 | 66.385 | 81.787 | -7.790 | 100.490▲ |
CDL | $GOSS Doji Candlestick Pattern Detected | Set Alert |
Friday, August 15, 2025 03:45 AM
NasdaqGS:GOSS 1 Year Share Price vs Fair Value Explore Gossamer Bio's Fair Values from the Community and select ...
|
Saturday, August 09, 2025 03:39 AM
Detailed price information for Gossamer Bio Inc (GOSS-Q) from The Globe and Mail including charting and trades.
|
Tuesday, August 05, 2025 01:14 PM
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 1.96 | 1.98 | 1.91 | 1.96 | 1,731,121 |
14/08/25 | 1.95 | 1.98 | 1.86 | 1.96 | 1,413,072 |
13/08/25 | 1.95 | 2.00 | 1.845 | 1.97 | 2,942,692 |
12/08/25 | 1.77 | 1.95 | 1.745 | 1.93 | 2,209,611 |
11/08/25 | 1.73 | 1.795 | 1.68 | 1.735 | 2,487,990 |
08/08/25 | 1.75 | 1.7897 | 1.665 | 1.76 | 3,070,404 |
07/08/25 | 2.00 | 2.02 | 1.715 | 1.74 | 3,782,644 |
06/08/25 | 2.18 | 2.21 | 1.92 | 1.98 | 3,966,370 |
05/08/25 | 2.175 | 2.23 | 2.0607 | 2.16 | 3,075,996 |
04/08/25 | 2.085 | 2.18 | 2.03 | 2.17 | 5,912,463 |
|
|
||||
|
|
||||
|
|